SEC Comment Letter 0000000000-25-001377 to Microbot Medical Inc. (MBOT)
Microbot Medical Inc.
Date: Feb. 7, 2025 · CIK: 0000883975 · Accession: 0000000000-25-001377
AI Filing Summary & Sentiment
File numbers found in text: 333-284688
Letter
February 7, 2025 Harel Gadot Chief Executive Officer Microbot Medical Inc. 288 Grove Street, Suite 388 Braintree, MA 02184 Re:Microbot Medical Inc. Registration Statement on Form S-1 Filed February 4, 2025 File No. 333-284688 Dear Harel Gadot: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Stephen E. Fox, Esq.
Show Raw Text
February 7, 2025
Harel Gadot
Chief Executive Officer
Microbot Medical Inc.
288 Grove Street, Suite 388
Braintree, MA 02184
Re:Microbot Medical Inc.
Registration Statement on Form S-1
Filed February 4, 2025
File No. 333-284688
Dear Harel Gadot:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Stephen E. Fox, Esq.